Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04079998 · ClinicalTrials.gov registry record · NA
Procellera® Compared to Standard of Care Treatment in Mitigating Biofilm Formation in Acute Trauma and Burn Wounds
A NA study of Trauma-related Wound and Burn, Partial Thickness, sponsored by The Metis Foundation.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT04079998 is a NA study of Trauma-related Wound and Burn, Partial Thickness that has completed, run by The Metis Foundation. The registered enrollment target is 38 participants, above the 20-participant average among 3 other Trauma-related Wound trials with a reported enrollment target (90% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04079998, a NA study of Trauma-related Wound and Burn, Partial Thickness, has completed, sponsored by The Metis Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to evaluate Procellera® , a novel FDA approved antimicrobial wound dressing in a prospective, randomized, controlled clinical study. The hypothesis is that when the dressing is moistened, the low electric field created by moisture-activated elemental silver and zinc electro-couple will prevent formation of biofilm in wounds or to disrupt existing biofilm.
Conditions Studied
Interventions
- OTHER Standard of Care
- DEVICE Procellera®
Study Locations (1)
Texas
- Brooke Army Medical Center - Fort Sam Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-02-28 |
| Est. Completion | 2020-12-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04079998
The ClinicalTrials.gov registry entry for NCT04079998 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 20-participant average among 3 other Trauma-related Wound trials with a reported enrollment target (90% higher). The listed sponsor is The Metis Foundation, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Trauma-related Wound appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT04079998 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04079998 about?
NCT04079998 is a clinical study titled "Procellera® Compared to Standard of Care Treatment in Mitigating Biofilm Formation in Acute Trauma and Burn Wounds". The objective of the study is to evaluate Procellera® , a novel FDA approved antimicrobial wound dressing in a prospective, randomized, controlled clinical study. The hypothesis is that when the dressing is moistened, the low electric field created by moisture-activated elemental silver and zinc ele...
What is the current status of trial NCT04079998?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-02-28. Estimated completion is 2020-12-03.
What conditions does trial NCT04079998 study?
This clinical trial studies the following conditions: Trauma-related Wound, Burn, Partial Thickness.
What interventions are being tested in trial NCT04079998?
The interventions under investigation include: Standard of Care (OTHER), Procellera® (DEVICE).
Who is sponsoring clinical trial NCT04079998?
This trial is sponsored by The Metis Foundation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04079998 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma-related Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
COMPLETED · Phase 1
-
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds
COMPLETED
-
StrataGraft Safety, Tolerability and Efficacy in Pediatric Subjects
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.